MYC and hematopoietic and lymphoid system neoplasm: Specifically, the SCLC cells with more malignant signatures, in particular, higher expression levels of MYC, upregulated pathways involving DNA replication and cell cycle and downregulated pathways on immune response, were far away from the other SCLC cells and close to hematological tumors, instead.